Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.

Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu YC, Kuo SY, Hsieh MJ, Hsueh C.

J Surg Oncol. 2012 Mar;105(3):288-92. doi: 10.1002/jso.22097. Epub 2011 Sep 19.

PMID:
21932407
2.

Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients.

Chao YK, Chuang WY, Yeh CJ, Wu YC, Liu YH, Hsieh MJ, Cheng AJ, Hsueh C, Liu HP.

J Surg Oncol. 2012 Feb;105(2):183-8. doi: 10.1002/jso.22068. Epub 2011 Aug 30.

PMID:
22213642
3.

High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

Yeh CJ, Chuang WY, Chao YK, Liu YH, Chang YS, Kuo SY, Tseng CK, Chang HK, Hsueh C.

Virchows Arch. 2011 Feb;458(2):171-8. doi: 10.1007/s00428-010-0994-5. Epub 2010 Nov 3.

PMID:
21046149
4.

Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.

Korkolopoulou P, Levidou G, El-Habr EA, Piperi C, Adamopoulos C, Samaras V, Boviatsis E, Thymara I, Trigka EA, Sakellariou S, Kavantzas N, Patsouris E, Saetta AA.

Histopathology. 2012 Aug;61(2):293-305. doi: 10.1111/j.1365-2559.2012.04236.x. Epub 2012 Jun 13.

PMID:
22690797
5.

Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.

Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.

Ann Surg. 2009 Mar;249(3):392-6. doi: 10.1097/SLA.0b013e3181949e9f.

PMID:
19247024
6.

Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.

Salehi Z, Mashayekhi F.

Clin Biochem. 2006 Apr;39(4):404-9. Epub 2005 Dec 20.

PMID:
16375881
7.

Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.

Fang Z, Lu L, Tian Z, Luo K.

Med Oncol. 2014 May;31(5):940. doi: 10.1007/s12032-014-0940-5. Epub 2014 Apr 6.

PMID:
24706262
8.

Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D.

Cancer Sci. 2009 Sep;100(9):1591-6. doi: 10.1111/j.1349-7006.2009.01224.x. Epub 2009 May 18.

9.

Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1352-9, 1359.e1. doi: 10.1016/j.jtcvs.2012.06.049. Epub 2012 Jul 25.

10.

CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.

Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H.

Ann Surg Oncol. 2009 Feb;16(2):506-14. doi: 10.1245/s10434-008-0252-0. Epub 2008 Dec 3.

PMID:
19050962
11.

Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.

Benavente S, Vergés R, Hermosilla E, Fumanal V, Casanova N, García A, Ramón Y Cajal S, Giralt J.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1316-22. doi: 10.1016/j.ijrobp.2009.01.004. Epub 2009 Apr 11.

PMID:
19362787
12.

COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.

Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A, Ikeda N, Mori M, Yoneyama Y, Endo S, Miyazawa Y, Matsubara H.

Ann Surg Oncol. 2011 Oct;18(10):2946-51. doi: 10.1245/s10434-011-1645-z. Epub 2011 Mar 25.

PMID:
21437756
13.

Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.

Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP.

J Surg Oncol. 2010 Aug 1;102(2):158-62. doi: 10.1002/jso.21588.

PMID:
20648587
14.

The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.

Hsu HS, Lin MH, Jang YH, Kuo TT, Liu CC, Cheng TH.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):378-85. doi: 10.1016/j.jtcvs.2014.09.047. Epub 2014 Sep 18.

15.

Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.

Gao C, Pang L, Ren C, Ma T.

Pathol Oncol Res. 2012 Apr;18(2):471-7. doi: 10.1007/s12253-011-9470-z. Epub 2011 Nov 19.

PMID:
22102006
16.

Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.

Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP.

Ann Surg Oncol. 2011 Feb;18(2):529-34. doi: 10.1245/s10434-010-1244-4. Epub 2010 Aug 10.

PMID:
20697822
17.

Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.

Jia Y, Wang N, Wang J, Tian H, Ma W, Wang K, Tan B, Zhang G, Yang S, Bai B, Cheng Y.

Ann Surg Oncol. 2014 Jan;21(1):329-36. doi: 10.1245/s10434-013-3225-x. Epub 2013 Aug 28.

PMID:
23982252
18.

Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.

Chao YK, Yeh CJ, Chuang WY, Fan KH, Hsieh MJ, Chu Y, Cheng AJ, Liu HP.

J Surg Oncol. 2009 Dec 1;100(7):559-62. doi: 10.1002/jso.21362.

PMID:
19653242
19.

Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Liao YJ, Zhang LJ, Guan XY, Zeng YX, Xie D.

Cancer Sci. 2009 Dec;100(12):2354-60. doi: 10.1111/j.1349-7006.2009.01349.x. Epub 2009 Sep 4.

20.

Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.

Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, Wang LS.

Ann Surg Oncol. 2009 Feb;16(2):352-60. doi: 10.1245/s10434-008-0242-2. Epub 2008 Dec 3.

PMID:
19050969

Supplemental Content

Support Center